Trial for potential malaria treatment Recent malaria trial participants have completed their five-day confinement phase, and their feedback is overwhelmingly positive. The attentive care provided by our staff was praised, ensuring their safety and comfort at all times. One of our participants, Kye, also commented on the high-quality and enjoyable meals tailored to their preferences. With comments like “Staff and doctors are great, always felt in very good hands”, our participants’ voices truly reflect our commitment to excellence. We’re actively looking for healthy participants and your assistance in helping us is greatly appreciated.
Participants at the UniSC Clinical Trials Moreton Bay clinic COVID-19 nasal spray trial triumph Announcing the successful completion of a phase one clinical trial for a potential nasal spray vaccine. As the single global site selected for this study, not only did we surpass our patient recruitment goal, but we’ve also redefined medical innovation. Under the leadership of Dr Rob Scott and our Senior Clinical Trials Coordinator, James Donkin, our Sippy Downs team ventured into uncharted territory. By directly targeting the virus’s point of entry through a nasal spray.
A heartfelt appreciation to our dedicated volunteers, the true driving force behind this research.
Currently recruiting trials:
Melanoma
Ovarian cancer
Breast cancer
Head and neck cancer
Non-small cell lung cancer
Migraine
Depression
Immune disorders
Coeliac disease
Upcoming trials:
Dry-eye disease
Healthy volunteer trials
Osteoarthritis Alcohol consumption